TrialAnnals of oncology : official journal of the European Society for Medical Oncology2015

Denosumab for the prevention of skeletal complications in metastatic castration-resistant prostate cancer: comparison of skeletal-related events and symptomatic skeletal events.

M R Smith et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.